NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
85.4%
Industry median - 64.9%
5Y Historical average - 84.2%
(15.3%)
Industry median - (879.7%)
5Y Historical average - (127.8%)
0.8%
Industry median - (720.0%)
5Y Historical average - (83.7%)
(4.8%)
Industry median - 83.4%
5Y Historical average - 28.2%
ALNY Profitability Rating
Crunching data... Almost there!
ALNY Profitability Metrics
Crunching data... Almost there!
Competing with ALNY Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Alnylam Pharmaceuticals, Inc. (ALNY) gross profit margin?
The Alnylam Pharmaceuticals, Inc. (ALNY) gross profit margin is 85.4%, compared to the industry median of 64.9% and the 5-year historical average of 84.2%.
What is the Alnylam Pharmaceuticals, Inc. (ALNY) operating income margin?
The Alnylam Pharmaceuticals, Inc. (ALNY) operating income margin is (15.3%), compared to the industry median of (879.7%)) and the 5-year historical average of (127.8%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF) margin?
The Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow margin is 0.8%, compared to the industry median of (720.0%) and the 5-year historical average of (83.7%).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) earnings quality?
The Alnylam Pharmaceuticals, Inc. (ALNY) earnings quality is (4.8%), compared to the industry median of 83.4% and the 5-year historical average of 28.2%.